Palliative treatment of germ cell cancer
Related Research units
Abstract
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.
Bibliographical data
| Original language | English |
|---|---|
| ISSN | 0305-7372 |
| DOIs | |
| Publication status | Published - 12.2018 |
| PubMed | 30415106 |
|---|
